Clay Thorp, Director at Clearside Biomedical, holds 3.59M shares in Clearside Biomedical (Ticker: CLSD), holds 3.58M shares in Phasebio Pharmaceuticals (Ticker: PHASQ), holds 1.56M shares in Vigil Neuroscience Inc (Ticker: VIGL). Most recently, Clay Thorp Bought ― shares of Clearside Biomedical on Sep 25, 2023 for an estimated value of 8.60K.
What is the percentage of profitable transactions made by Clay Thorp?
The percentage of profitable transactions made by Clay Thorp is 64%.
What is the average return per transaction made by Clay Thorp?
The average return per transaction made by Clay Thorp is 29.80%.
What stocks does Clay Thorp hold?
Clay Thorp holds: CLSD, GTHX, PHASQ, VIGL stocks.
What was Clay Thorp’s latest transaction?
Clay Thorp latest transaction was an Informative Buy of $8.60K.
What was Clay Thorp's most profitable transaction?
Clay Thorp’s most profitable transaction was an Informative Buy of VIGL stock on May 17, 2022. The return on the trade was 168.80%.
What is Clay Thorp's role in Clearside Biomedical?
Clay Thorp's role in Clearside Biomedical is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.